3 Year Returns
23.14%
NAV (₹)
263.7903
1 Day NAV Change
-0.44%
UTI-Healthcare Fund IDCW is a scheme from UTI Mutual Fund AMC, launched on 28 Jun 1999 and currently managing ₹ 1443.57 Cr in assets. It sits in the very high risk category on the riskometer, with a minimum SIP of ₹500 and a lump sum of ₹5000. The sections below cover its latest NAV, historical returns, portfolio holdings, and expense ratio.
UTI-Healthcare Fund IDCW Fund Details
| Min. SIP Amount | ₹ 500 |
| Min. Lumpsum Amount | ₹ 5000 |
| AUM | ₹ 1443.57 Cr |
| Expense Ratio | 2.2% |
| Lock-in Period | No Lock-in Period |
| Inception Date | 28 Jun 1999 |
| Fund Age | 27 Yrs |
Exit Load
1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment.
Fund’s Investment Objective
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Calculate Your Mutual Fund Returns
Returns Estimator
Estimation is based on the past performance
Expected Rate of Return
The value of your investment after 5 Years will be
₹4,12,432
Invested Amount
₹3,00,000
Est. Returns
₹1,12,432
Scheme’s Historical Return
Asset Allocation
AUM
₹1,33,309.00 Cr
Cash Holdings
21.45%
Equity
70.84%
Cash
21.45%
Debt
1.71%
Other
6%
UTI-Healthcare Fund IDCW Sector Holdings
Last Updated: 31 Aug 2026| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Pharmaceuticals | 72.00% | ₹ 1,039.342 | |
| Healthcare | 26.49% | ₹ 382.412 | |
| Chemicals | 1.51% | ₹ 21.815 |
UTI-Healthcare Fund IDCW Stock Holdings
Last Updated: 31 Aug 2026| Name | Allocation | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|---|
| Sun Pharma.Inds. | 8.25% | ₹ 119.088 | Pharmaceuticals | |
| Divi's Lab. | 6.21% | ₹ 89.659 | Pharmaceuticals | |
| Net CA & Others | 5.71% | ₹ 82.414 | Debt Others | |
| Ajanta Pharma | 4.74% | ₹ 68.436 | Pharmaceuticals | |
| Gland Pharma | 3.70% | ₹ 53.387 | Pharmaceuticals | |
| Dr Reddy's Labs | 3.62% | ₹ 52.311 | Pharmaceuticals | |
| Alkem Lab | 3.29% | ₹ 47.433 | Pharmaceuticals | |
| Apollo Hospitals | 3.27% | ₹ 47.162 | Healthcare | |
| Max Healthcare | 3.10% | ₹ 44.81 | Healthcare | |
| Lupin | 3.09% | ₹ 44.607 | Pharmaceuticals |
Fund Manager Details
Risk-O-Meter
Investors understand that their principal will be at Very High Risk
Risk Scale
AMC Information
UTI Mutual Fund
Funds Managed
86
Assets Managed
₹ 3,94,847.58 Cr
Contact Details
Registered Address
UTI Towers, Gn Block,Bandra Kurla Complex,Bandra (East), Mumbai 400 051
Managing Director
Vetri Subramaniam
Chief Executive Officer
Vetri Subramaniam
Compliance Officer
Gayatri Kannan
Mutual Funds Calculators
Explore Mutual Funds by Types
Open NFOs
Explore Popular AMCs
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
Download the AR Invest App
- 5000+ Schemes
- Personalized Solutions
- Expert Insights
